generic glp-1 agonist Letter: Association Between Incretin Mimetics and Medullary Thyroid Cancer glp-1 agonist weight loss medications
Description
doi:10.1002/lt.25694 13
doi: 10.1194/jlr.R075481 64 Martin-SeguraAAhmedTCasadome-PeralesAPalomares-PerezIPalomerEKerstensAet al
Crucially, they trigger insulin release only when glucose is already present in the bloodstream, minimizing the risk of dangerous hypoglycemia seen with some older diabetes drugs
10.1111/dom.12506
Globally prominent therapies include semaglutide and tirzepatide
Additionally, semaglutides longer half-life allows for convenient weekly injections, unlike daily administration required by other similar medications
